NCT03664882View on ClinicalTrials.gov

Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

January 3, 2019

Study Completion Date

January 3, 2019

Conditions
Rhinitis Seasonal
Interventions
DRUG

Fexofenadine M016455

Pharmaceutical form: tablet Route of administration: oral

DRUG

Placebo

Pharmaceutical form: tablet Route of administration: oral

Trial Locations (1)

Unknown

Investigational Site Number, Canada

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT03664882 - Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants | Biotech Hunter | Biotech Hunter